Andrew McKee
Biomedical Engineering graduate with MD from Duke University. Last worked at Google as Senior associate, Business Operations and Strategy.
| Headline: | Entrepreneur |
| Website: | http://mckee.wordpress.com |
| Skills: | C/C++, HTML / CSS, Languages and Platforms, Python, Software Engineering, Web Development |
| Location: | San Francisco |
| Groups: | BASES, Social e-challenge Competition 2009 [inactive] |
| Interested in: | Brainstorming, Finding business partners, Finding cofounders, Finding team mates, Meeting new people, Professional opportunities, Promoting my startups, Recruiting for my startup |
| Tags: | bay area, Biotechnology, clean tech, Health care, infectious diseases, investment due diligence, management, operations, r&d, research, silicon valley, Strategy, water |
| Schools: | Duke University |
WORK EXPERIENCE
| Employer: | Google, Inc., Mountain View, CA |
| Position: | Senior associate, Business Operations and Strategy. Internal business consultant |
| Time period: | January 2008 - August 2008 |
| Description: | Project #1: Clients were SVPs. Successfully created HR integration tools and comanaged
the integration of 2,000 employees for Google’s largest acquisition (DoubleClick) without suffering declines in either company’s revenue or customer base. Project #2: Clients were the CEO and SVPs. Conducted expert interviews, market analyses, and helped create a financially-aligned “business unit” structure. Identified strategic areas for products to capture over $1 billion in 2009 revenue. Side Project: Clients were google.org executives. Conducted due diligence (technology, market strategy) and made recommendations for a global health investment. |
| Employer: | McKinsey & Company, Palo Alto, CA |
| Position: | Senior associate consultant |
| Time period: | June 2006 - November 2007 |
| Description: | Worked on business strategy (60% of projects) and operations (40%).
Served clients in industries including biotechnology, pharmaceuticals, private equity (healthcare), private equity (consumer packaged goods), hospital providers, auto insurance, and asset management. Presented findings to CEOs and other executives, analyzed large data sets, built complex financial models, identified trends by interviewing experts, conducted market research, managed client implementation teams, created internal marketing materials, executed marketing events, analyzed molecular pathways of pathogenesis, and programmed data-analysis tools for immediate client use. For multiple clients, identified and made recommendations for multi-million dollar growth strategies. |
| Employer: | Duke University, Dept. of Pharmacology & Cancer Biology, Durham, NC |
| Position: | Medical student researcher |
| Time period: | July 2003 - July 2004 |
| Description: | PI: Tso-Pang Yao, PhD. Designed and executed experiments to explore the molecular role of HDAC12 in protein accumulations of insulinoma and diabetes-phenotype islet cells. Designed and implemented novel genetic screen experiments to identify nuclear chaperone proteins in s. cerevisiae. |
| Employer: | Duke University, Dept. of Anesthesia, Durham, NC |
| Position: | Researcher, clinical trials |
| Time period: | December 2001 - December 2003 |
| Description: | PI's: Randy Brewer MD, David Warner MD, PhD. At nights during 2nd and 3rd years of medical school, I consented patients, analyzed data, and drew conclusions for a small clinical trial. The trial had significant negative findings, in that we demonstrated that a potential neuroprotectant drug does not substantially increase concentration in the brain when given intravenously. |
| Employer: | Duke University, Dept. of Biomedical Engineering, Durham, NC |
| Position: | Researcher, biomedical engineering and physiology |
| Time period: | December 1999 - December 2001 |
| Description: | PI’s: Laura Niklason MD, PhD, Chris Counter, PhD, Cecil Borel, MD. From junior year college to 1st year medical school, I led two projects to design tissue-engineered human arteries and investigate the pathophysiology of cerebral vasospasm after subarachnoid hemorrhage (SAH). In the first project, I extended the lifespan of vascular cells, validated their non-oncogenic phenotype, analyzed vessel wall mechanics with video capture, and engineered arteries in vitro with pulsed-flow bioreactors. In the second, I created an in vitro model of vasospasm to understand the role of growth factors and analyzed cerebrospinal fluid (CSF) of SAH patients. |
| Employer: | Independent and Mook's Music, LLC, Durham, NC |
| Position: | Saxophonist, composer, owner, operator, band leader, music arranger |
| Time period: | July 1999 - June 2006 |
| Description: | I performed professionally and with many famous jazz musicians including Branford Marsalis, Paul Jeffrey, and Lou Donaldson. Fluent in genres including all jazz styles, Latin styles, gospel, funk, reggae, R&B, classical and more. Listen: amckee.com/music |
| Employer: | National Institutes of Health, NHLBI, Renal Mechanisms Section, Bethesda, MD |
| Position: | Researcher, renal proteomics |
| Time period: | May 1999 - July 2000 |
| Description: | PI: Mark Knepper, MD, PhD. As an inaugural fellow of the Whitaker Foundation and the NIH, during 2 summers I studied the expression of kidney proteins in the urine. I identified a novel correlation between types of kidney injury and the expression of urinary proteins, which opened the possibility for novel urinary diagnostics (this work still in progress). |
| Employer: | Duke University, Dept. of Chemistry, Durham, NC |
| Position: | Researcher, drug delivery |
| Time period: | July 1998 - April 1999 |
| Description: | PI: Eric Toone, PhD. During my 2nd year of college I optimized a polymerization reaction to create a tough, durable polymer, capable of coating angioplasty stents, and sustained release of nitric oxide from RNO bonds within the polymer. This formed the basis for animal trials with Boston Scientific. |
EDUCATION
| University: | Duke University |
| Time period: | 2000 - 2005 |
| Degree: | Achieved MD |
| University: | Duke University |
| Time period: | 1996 - 2000 |
| Degree: | Biomedical Engineering, BSc |
PUBLICATIONS
| Papers: | 1. McKee JA et al. Analysis of the brain bioavailability of peripherally administered
MgSO4: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Medicine 33(3):661-6 (2005). 2. McKee JA et al. Magnesium neuroprotection is limited in humans with acute brain injury. Neurocrit Care. 2(3):342-51 (2005). 3. McKee JA and Yao TP. Histone deacetylases in the response to misfolded proteins. In: Verdin E., ed. Histone Deacetylases, 1st ed., Totowa: Humana Press (2005). 4. Borel CO, McKee A et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke 34(2):427-33 (2003). 5. McKee JA et al. Human arteries engineered in vitro. EMBO Reports 4(6): 633-8 (2003). 6. McKee JA et al. Detection of Na(+) transporter proteins in urine. J Am Soc Nephrol. 11(11):2128-32 (2000). 7. Niklason LE, McKee JA, Counter CM. “Tissue Engineering”, US Patent #10388588. 8. Niklason LE, McKee JA, Borel C. "Therapy for Cerebral Vasospasm", US Patent #10074250. |
INFORMATION
| Hobbies: | Regular activities: saxophone, sharing life with my wife, yoga, meditation, hiking, reading,
writing, Japanese, and volunteering as a BUILD high school mentor in Oakland. |
Andrew's Contacts (8)
View all-
Andrew Chen
Andrew Chen is a blogger and startup executive focused on advertising and social media. He writes the blog Futuristic Play (andrewchen.typepad.com) and was most recently an Entrepreneur-in-Residence at Mohr Davidow Ventures, a $2B VC fund in SF
-
-
-
Sean Gourley
CTO & co-founder of Quid. Building the next generation intelligence platform.